Protective effect of mixture of ginkgolide A and ginkgolide B on permanent focal cerebral ischemia in rats

Chinese Traditional and Herbal Drugs

Volumn 38, Issue 2, 2007, Pages 241-244

  Wang, Xuan ^a,b   Gu, Zhen Lun ^a   Qin, Zhen Hong ^a   Zhang, Hui Ling ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Neurosurgery Department   (China)

Author keywords

Cerebral ischemia; Ginkgolide A; Ginkgolide B; Middle cerebral artery occlusion (MCAO)

Indexed keywords

GINKGOLIDE A PLUS GINKGOLIDE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIVE AGENT; NIMODIPINE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG MIXTURE; DRUG RESPONSE; GRANULE CELL; HISTOPATHOLOGY; NONHUMAN; RAT;

EID: 34047220123     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kassem-Moussa H, Graffagnino C. Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies [J]. Arch Neurol, 2002, 59: 1870-1873.
2. Kaltschmidt B, Heinrich M, Kaltschmidt C. Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells [J]. Neuromolecular, 2002, (2): 299-309.
3. Pizzi M, Goffi F, Boroni F, et al. Opposing roles for NF-kappaB/Rel factors p65 and c-Rel in the modulation of neuronal survival elicited by glutamate and interluelin-1 beta [J]. J Biol Chem, 2002, 277: 20717-20723.
4. Ryan K M, Ernst M K, Rice N R, et al. Role of NF-κB in p53-mediated programmed cell death [J]. Nature, 2000, 404: 892-897.
5. Carrrol J E, Howard E F, Hess D C, et al. Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment [J]. Brain Res Mol Brain Res, 1999, 56: 186-191.
6. Clement J A, Stephenson D T, Dixon E P, et al. Global cerebral ischemia activates nuclear factor-κB prior to evidence of DNA fragmentation [J]. Mol Brain Res, 1997, 48: 187-196.
7. Clemens J A, Stephenson D T, Yin T, et al. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-κ3 in rats [J]. Stroke, 1998, 29: 677-682.
8. Schneider A, Martin-Villalba, Weih F, et al. NF-κB is activated and promotes cell death in focal cerebral ischemia [J]. Nature Med, 1999, 5:554-559.
9. Stephenson D, Yin T, Smalstig E B, et al. Transcription factor nuclear factor-kappaB is activated in neurons after cerebral ischemia [J]. J Cereb Blood flow Metab, 2000, 20: 592-603.
10. Nurmi A, Vartiainen N, Koistinaho M, et al. Functional role of nuclear factor kappa-B in ischemic stroke [J]. Stroke, 2004, 35: 987-991.
11. Ueno T, Sawa Y, Kitagawa-Sakakida S, et al. Uuclear factor-kappa decoy attenuaes neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest [J]. J Thorac Cardiovasc Surg, 2001, 122: 720-727.
12. Zhang W, Potrovita I, Tarabin V, et al. Neuronal activation of NF-κB contributes to cell death in cerebral ischemia [J]. J Cereb Blood Flow Metab, 2005, 25: 30-40.
13. Imai H, Graham D I, Masayasu H, et al. Anti-oxidant ebselen reduces oxidative damage in focal cerebral ischemia [J]. Free Radic Biol Med, 2003, 34: 56-63.
14. Pei Z, Pang S F, Cheung R T. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke mode [J]. Stroke, 2003, 34: 770-775.
15. Wu X F, Wang Q J, Lou F C. Protective effect of ginkgolides on rat focal brain ischemia [J]. J China Pharm Unit 2001, 32(2): 141-145.
16. 2 and expression of ginkgolides immediate early genes [J]. Chin J Clin Pharmacol Ther 2003, 34(4): 401.